Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22
|
pubmed:dateCreated |
1993-12-10
|
pubmed:abstractText |
Several 5-iodotubercidin analogues in the pyrazolo[3,4-d]pyrimidine ring system were synthesized as potential inhibitors of adenosine kinase by a direct Lewis acid-catalyzed glycosylation procedure using both the preformed carbohydrate and the heterocyclic base as starting materials. The 5'-hydroxyl, -chloro, -azido, -deoxy, -amino, and -fluoro derivatives were prepared and evaluated in three systems for biological activity relative to adenosine, the true substrate, and 5-iodotubercidin, a known inhibitor. First, each compound was studied kinetically for inhibition of purified human placental adenosine kinase activity. The order of potency was: iodotubercidin > hydroxyl > amino > or = deoxy > fluoro > chloro >> azido. The Ki values for the 5'-hydroxyl and 5'-amino compounds, the two most potent inhibitors, were 80 and 150 nM, respectively. The inhibition appeared to be essentially competitive in nature, although a noncompetitive component of significance for the more potent inhibitors cannot be ruled out. Second, a bioassay was conducted in which the toxicity of 6-methylmercaptopurine riboside toward human CEM lymphoblasts was reversed by varying concentrations of the compounds. The order of effectiveness of the compounds in this system, representing a functional inhibition of adenosine kinase in cultured cells, was about the same as that with the purified enzyme, except that the 5'-chloro and 5'-fluoro compounds were ineffective. Third, the 5'-hydroxyl derivative was evaluated in vivo in a rat pleurisy inflammation model and displayed biological activity at a dose of 30 mg/kg given orally. Finally, the in vitro toxicity of each compound was assessed in CEM lymphoblasts. Results indicated that the two most potent inhibitors in the pyrazolo[3,4-d]pyrimidine ring system, the 5'-hydroxyl (7) and the 5'-amino (20), were 15-fold and 75-fold, respectively, less growth inhibitory than 5-iodotubercidin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5-iodotubercidin,
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Carrageenan,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/Tubercidin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3424-30
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8230132-Adenosine Kinase,
pubmed-meshheading:8230132-Administration, Oral,
pubmed-meshheading:8230132-Animals,
pubmed-meshheading:8230132-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:8230132-Carrageenan,
pubmed-meshheading:8230132-Cells, Cultured,
pubmed-meshheading:8230132-Drug Evaluation, Preclinical,
pubmed-meshheading:8230132-Humans,
pubmed-meshheading:8230132-Kinetics,
pubmed-meshheading:8230132-Lymphocytes,
pubmed-meshheading:8230132-Pleurisy,
pubmed-meshheading:8230132-Pyrazoles,
pubmed-meshheading:8230132-Pyridines,
pubmed-meshheading:8230132-Rats,
pubmed-meshheading:8230132-Rats, Sprague-Dawley,
pubmed-meshheading:8230132-Tubercidin
|
pubmed:year |
1993
|
pubmed:articleTitle |
New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation.
|
pubmed:affiliation |
Department of Medicine, University of California, San Diego, La Jolla 92093-0663.
|
pubmed:publicationType |
Journal Article
|